A Phase 1 Dose Escalation Trial of Ex-Vivo Expanded Allogeneic Cord Blood–derived Natural Killer Cell Immunotherapy for Pediatric Solid Tumor Malignancies.
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)